External validation of prognostic models: What, why, how, when and where?

455Citations
Citations of this article
434Readers
Mendeley users who have this article in their library.

Abstract

Prognostic models that aim to improve the prediction of clinical events, individualized treatment and decision-making are increasingly being developed and published. However, relatively few models are externally validated and validation by independent researchers is rare. External validation is necessary to determine a prediction model's reproducibility and generalizability to new and different patients. Various methodological considerations are important when assessing or designing an external validation study. In this article, an overview is provided of these considerations, starting with what external validation is, what types of external validation can be distinguished and why such studies are a crucial step towards the clinical implementation of accurate prediction models. Statistical analyses and interpretation of external validation results are reviewed in an intuitive manner and considerations for selecting an appropriate existing prediction model and external validation population are discussed. This study enables clinicians and researchers to gain a deeper understanding of how to interpret model validation results and how to translate these results to their own patient population.

Cite

CITATION STYLE

APA

Ramspek, C. L., Jager, K. J., Dekker, F. W., Zoccali, C., & Van DIepen, M. (2021, January 1). External validation of prognostic models: What, why, how, when and where? Clinical Kidney Journal. Oxford University Press. https://doi.org/10.1093/ckj/sfaa188

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free